T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Regal Rexnord
RRX
$11.4B
| $186M | 0.02% |
1,092,530
+580,111
| +113% | +$91.9M |
|
577
APA Corp
APA
$13.9B
| $186M | 0.02% |
6,905,058
+1,329,254
| +24% | +$35.3M |
|
578
Parker-Hannifin
PH
$133B
| $184M | 0.02% |
578,329
+5,207
| +0.9% | +$1.61M |
|
579
Coca-Cola Consolidated
COKE
$12.7B
| $184M | 0.02% |
2,970,140
-40,940
| -1% | -$2.02M |
|
|
RNAM
580
DELISTED
Avidity Biosciences
RNAM
| $184M | 0.02% |
7,731,846
+641,196
| +9% | +$15.3M |
|
581
LegalZoom.com
LZ
$944M
| $183M | 0.02% |
11,396,479
+6,053,925
| +113% | +$128M |
|
582
Monster Beverage
MNST
$91.4B
| $183M | 0.02% |
7,613,620
+133,216
| +2% | +$2.96M |
|
583
Strategic Education
STRA
$1.83B
| $183M | 0.02% |
3,155,258
+164,496
| +6% | +$10.3M |
|
|
TPTX
584
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $182M | 0.02% |
3,811,568
+525,687
| +16% | +$23.5M |
|
585
Middlesex Water
MSEX
$1.11B
| $182M | 0.02% |
1,509,295
-127,573
| -8% | -$13.6M |
|
586
Expro Ltd
XPRO
$2.06B
| $181M | 0.02% |
12,609,221
+5,502,629
| +77% | +$90.1M |
|
587
IBM
IBM
$221B
| $181M | 0.02% |
1,351,226
-112,896
| -8% | -$14.2M |
|
588
CDW
CDW
$17.2B
| $180M | 0.02% |
881,334
-138,384
| -14% | -$26.3M |
|
589
McKesson
MCK
$100B
| $177M | 0.02% |
713,585
-90,318
| -11% | -$19.8M |
|
590
Voya Financial
VOYA
$9.09B
| $177M | 0.02% |
2,669,967
+1,430,331
| +115% | +$94.2M |
|
591
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.38B
| $175M | 0.02% |
3,299,570
-10,393
| -0.3% | -$601K |
|
|
BDXB
592
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $175M | 0.02% |
+3,320,371
| New | +$174M |
|
593
NVR
NVR
$17B
| $175M | 0.02% |
29,583
-391
| -1% | -$2.06M |
|
|
RDS.B
594
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $175M | 0.02% |
4,029,828
+139,599
| +4% | +$6.3M |
|
|
BWIN
595
Baldwin Insurance Group
BWIN
$2.94B
| $174M | 0.02% |
4,820,435
-50,564
| -1% | -$1.87M |
|
596
Target
TGT
$70.3B
| $173M | 0.02% |
747,328
-40,110
| -5% | -$9.75M |
|
597
AerCap
AER
$23.5B
| $172M | 0.02% |
2,630,797
+71,195
| +3% | +$4.41M |
|
|
OLK
598
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $171M | 0.02% |
9,420,850
+2,474,187
| +36% | +$61M |
|
|
CHX
599
DELISTED
ChampionX
CHX
| $171M | 0.02% |
8,461,021
+200,471
| +2% | +$4.71M |
|
600
McCormick & Company Non-Voting
MKC
$14.5B
| $170M | 0.02% |
1,764,123
-28,077
| -2% | -$2.39M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.